WO2013140821A1 - Corps stratifié pour emballage en ptp ou coque, et emballage en ptp ou coque - Google Patents

Corps stratifié pour emballage en ptp ou coque, et emballage en ptp ou coque Download PDF

Info

Publication number
WO2013140821A1
WO2013140821A1 PCT/JP2013/001972 JP2013001972W WO2013140821A1 WO 2013140821 A1 WO2013140821 A1 WO 2013140821A1 JP 2013001972 W JP2013001972 W JP 2013001972W WO 2013140821 A1 WO2013140821 A1 WO 2013140821A1
Authority
WO
WIPO (PCT)
Prior art keywords
ptp
layer
blister pack
skin layer
olmesartan medoxomil
Prior art date
Application number
PCT/JP2013/001972
Other languages
English (en)
Japanese (ja)
Inventor
高橋　正昭
弘 谷口
小川　達也
小泉　真一
山本　光
みどり 藤崎
Original Assignee
第一三共株式会社
共同印刷株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 第一三共株式会社, 共同印刷株式会社 filed Critical 第一三共株式会社
Priority to KR1020147023325A priority Critical patent/KR20140124790A/ko
Priority to JP2014506051A priority patent/JP6175425B2/ja
Priority to CN201380009766.XA priority patent/CN104169187A/zh
Publication of WO2013140821A1 publication Critical patent/WO2013140821A1/fr

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/18—Layered products comprising a layer of synthetic resin characterised by the use of special additives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2250/00—Layers arrangement
    • B32B2250/24—All layers being polymeric
    • B32B2250/242—All polymers belonging to those covered by group B32B27/32
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2264/00—Composition or properties of particles which form a particulate layer or are present as additives
    • B32B2264/10—Inorganic particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2270/00—Resin or rubber layer containing a blend of at least two different polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2307/00—Properties of the layers or laminate
    • B32B2307/70—Other properties
    • B32B2307/724—Permeability to gases, adsorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2307/00—Properties of the layers or laminate
    • B32B2307/70—Other properties
    • B32B2307/726—Permeability to liquids, absorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2439/00—Containers; Receptacles
    • B32B2439/80—Medical packaging

Definitions

  • the present invention relates to a PTP or blister pack laminate used for molding a PTP or blister pack, a PTP or blister pack molded using the same, and its usage.
  • PTP Pressure-Through Package
  • capsules containing solid preparations such as tablets and drugs.
  • PTP or blister packs are also collectively referred to as blister packaging containers and are widely used for packaging pharmaceutical products.
  • the laminate for PTP or blister pack is a film or sheet material used for forming PTP or blister pack before the preparation is enclosed.
  • a PTP or blister pack molding machine forms a dome-shaped (or bowl-shaped) pocket portion by applying heat (preheating) to a sheet-like laminate as a material while pressing it with a molding die.
  • the PTP or blister pack formed from the laminate is a package in which the preparation is sealed by thermally welding a lid material to the hem part extending around the periphery in a state where the preparation is accommodated inside the pocket portion. Become. If the PTP or blister pack is transparent, it is possible to easily visually recognize the preparation enclosed therein. Further, the encapsulated preparation can be easily taken out by pushing the PTP or blister pack together with a finger or the like so that the lid material breaks through. The name “press-through package” comes from this form of use.
  • PTP or blister packs There are various drugs that are active ingredients of preparations contained in PTP or blister packs, including drugs with low moisture resistance, drugs that are easily oxidatively decomposed, and drugs with strong odors. Therefore, it is desired that the PTP or blister pack has a function of absorbing liquid (water, etc.) and gas (water vapor, oxygen, smell, etc.).
  • an absorbent layer containing an absorbent is formed inside a PTP or blister pack in advance to give the molded PTP or blister pack an absorption function (International Publication WO2006 / 115264). : Patent Document 1).
  • Olmesartan medoxomil is used for hypertension or a disease derived from hypertension (more specifically, hypertension, heart disease [angina, myocardial infarction, arrhythmia, heart failure or hypertrophy), kidney disease [diabetic nephropathy, thread Spherical nephritis or nephrosclerosis] or cerebrovascular disease [cerebral infarction or cerebral hemorrhage]).
  • heart disease angina, myocardial infarction, arrhythmia, heart failure or hypertrophy
  • kidney disease diabetic nephropathy, thread Spherical nephritis or nephrosclerosis
  • cerebrovascular disease Cerebral infarction or cerebral hemorrhage
  • This olmesartan medoxomil is a compound having a medoxomil group in the molecule, and the low molecular weight 2,3-butanedione (hereinafter referred to as “diacetyl”) is obtained by gradually cleaving the medoxomil ester by water to change into an active body. It is a generated compound.
  • This diacetyl itself is known as a causative substance of a unique odor, and is considered to be an odor causative substance of a preparation containing olmesartan medoxomil.
  • a film for PTP or blister pack is formed of a laminate, a barrier layer is disposed on the outermost layer, and a moisture absorbing layer is disposed on the inner layer.
  • the hygroscopic layer has a three-layer structure of a main hygroscopic layer and a sub hygroscopic layer, and the sub hygroscopic layer is disposed on the inner and outer (upper and lower sides in the stacking direction) with the main hygroscopic layer interposed therebetween.
  • the outer sub-moisture absorbing layer enhances the adhesiveness with the barrier layer by lamination
  • the inner sub-hygroscopic layer enhances the adhesiveness with the lid material by heat sealing.
  • the inventors of the present invention when the barrier layer referred to in the prior art is a base material layer, the main moisture absorption layer is an intermediate layer, and the sub moisture absorption layers on both sides are an outer skin layer and an inner skin layer, PTP Or the following problems were faced in the laminated body for blister packs.
  • the inner skin layer facing the heating member may be fused to the heating member (improvement of preheat resistance).
  • the inner skin layer in contact with the contents such as the preparation is required not only to have preheat resistance but also to have a property of allowing the odor and moisture to permeate efficiently and improving the absorbability in the intermediate layer (improvement of absorption characteristics).
  • the inventors of the present invention have optimized the selection of the resin material used for the inner skin layer, and at the same time, optimized the mixing ratio (mass%) of the resin material, so that it can be used for PTP or blister packs. It came to invent a laminated body.
  • This laminate for PTP or blister pack has (1) sufficient preheat resistance at the time of molding PTP or blister pack, and (2) has sufficient absorption characteristics depending on the purpose of use.
  • one aspect of the present invention is a PTP or blister pack laminate comprising a base material layer and an absorption layer.
  • the base material layer becomes the outermost layer during molding as a PTP or blister pack.
  • the absorption layer is laminated
  • the above-mentioned absorption layer has a configuration in which an outer skin layer, an intermediate layer, and an inner skin layer are laminated in this order, and the outer skin layer is bonded to the base material layer via the adhesive layer.
  • the outer skin layer is made of a polyethylene resin
  • the intermediate layer is made of a mixture of a polyethylene resin and an absorbent.
  • the inner skin layer is made of a blend resin having 25 to 50% by mass of linear low density polyethylene and 75 to 50% by mass of high density polyethylene having a melting point higher than the preheating temperature in the molding process.
  • the inner skin layer is made of a blend resin having 10 to 50% by mass of linear low-density polyethylene and 90 to 50% by mass of high-density polyethylene having a melting point higher than the preheating temperature in the molding process. Become.
  • the above intermediate layer is composed of a mixture of a polyethylene resin and an absorbent, and forms the core of a functional layer that mainly absorbs moisture and odors.
  • the absorbent is preferably a synthetic zeolite.
  • the PTP or blister pack which is another embodiment of the present invention is formed using the above-described PTP or blister pack laminate. That is, the PTP or blister pack is laminated with a base material layer constituting the outermost layer of the pocket portion containing the contents, and an adhesive layer on the base material layer, and faces at least one of liquid and gas facing the contents. And an absorption layer that absorbs water.
  • the absorbent layer has a configuration in which an outer skin layer, an intermediate layer, and an inner skin layer are laminated in this order, and the outer skin layer is bonded to the base material layer through an adhesive layer, and the outer skin layer is made of polyethylene resin. Consists of.
  • the intermediate layer is made of a mixture of a polyethylene resin and an absorbent.
  • the inner skin layer is composed of a blend resin having 25 to 50% by mass of linear low-density polyethylene and 75 to 50% by mass of high-density polyethylene having a melting point higher than the preheating temperature in the molding process.
  • the inner skin layer is made of 10-50% by mass of linear low-density polyethylene and high-density polyethylene having a melting point higher than the preheating temperature in the molding process. It is composed of a blend resin having 90 to 50% by mass.
  • the material which has the advantage as a laminated body mentioned above the quality as a PTP or blister pack or a package using the same is improved, and the formulation which is the content is The odor generated can be suitably absorbed.
  • the pharmaceutical uses of the present invention are as follows.
  • a PTP package or blister pack comprising the PTP or blister pack described above and a preparation contained in the PTP or blister pack.
  • the method for reducing odor according to (8), wherein the preparation containing olmesartan medoxomil is a preparation containing olmesartan medoxomil further containing one or more of other drugs as an active ingredient.
  • the invention disclosed herein provides a laminate suitable for molding a PTP or blister pack having an absorption function.
  • the quality and reliability of the PTP or blister pack formed using the laminate can be improved, the absorption function can be fully exhibited, and the odor generated from the preparation can be reduced. It becomes possible to provide a package that hardly senses odor when the preparation is taken out from the PTP package or the blister package.
  • FIG. 1 is a longitudinal sectional view schematically showing the structure of a blister package
  • FIG. 2 is a longitudinal sectional view schematically showing the structure of a laminate that is a material of PTP or blister pack
  • FIG. 3 is a list showing the brand, model number, manufacturer name, melting point, etc. of the resin used in the laminate
  • FIG. 4 is a list showing the verification results of the experimental samples (Nos. 1 to 14) regarding the layer configuration example
  • FIG. 5 is a diagram showing the absorption rate when each sample of the laminate is exposed to diacetyl gas for 10 hours
  • FIG. 6 is a table showing the results of odor sensory tests with actual drugs.
  • FIG. 1 is a longitudinal sectional view schematically showing the structure of a PTP package or blister package 10 in a form in which the preparation 20 is enclosed in a PTP or blister pack 40.
  • the PTP package or blister pack 10 is an example of using a PTP or blister pack 40 formed using a PTP or blister pack laminate of materials.
  • Such a PTP package or blister package 10 is suitable for applications in which a tablet, granular or capsule-shaped preparation 20 is individually packaged.
  • the shape of the PTP or blister pack 40 can be variously changed depending on the outer shape of the preparation 20 to be contained.
  • the PTP or blister pack 40 has a dome shape, but the PTP or blister pack 40 may have a hollow cylindrical shape, a truncated cone shape, a prismatic shape, or a truncated pyramid shape.
  • the PTP or blister pack 40 is formed into a long and thin hollow protruding shape according to the outer shape of the capsule.
  • Such a PTP or blister pack 40 is obtained by forming a film-like or sheet-like laminate (a laminate for PTP or blister pack) as a material (raw material).
  • Examples of the method for forming the PTP or blister pack 40 from the laminate of materials include PTP forming methods such as a flat plate pressure forming method, a plug assist pressure forming method, a drum type vacuum forming method, and a plug forming method.
  • the PTP or blister pack 40 has a pocket portion 40a inside, and protects the formulation 20 in a state where the formulation 20 is accommodated in the pocket portion 40a. Further, a flat hem portion 40b extends around the pocket portion 40a, and the hem portion 40b serves as a base (or flange) of the PTP or blister pack 40.
  • FIG. 1 shows only a cross section of one blister package 10, but a plurality of PTP or blister packs 40 may be connected via, for example, a hem portion 40 b.
  • the skirt portion 40b is a single substrate, a plurality of PTPs or blister packs 40 are arranged in a matrix on the substrate.
  • Half-cut lines and perforations (not shown) for dividing individual PTPs or blister packs 40 or their rows can be formed in the skirt portion 40b serving as a substrate.
  • the blister package 10 has a structure in which the preparation 20 is housed in a PTP or blister pack 40 and sealed with a lid 30.
  • the lid member 30 is a film-like or sheet-like member having, for example, airtightness (gas barrier property and water vapor barrier property).
  • PVC Poly Vinyl Chloride; polyvinyl chloride
  • EVA Ethylene Vinyl Acetate; ethylene vinyl acetate copolymer resin
  • AL aluminum
  • the lid member 30 and the PTP or blister pack 40 are bonded together by heat-sealing them with their inner surfaces overlapped. If the adhesiveness is insufficient as it is, an adhesive layer or a heat-sealable resin layer may be further formed on either the lid member 30 or the PTP or blister pack 40.
  • the PTP package or the blister package 10 in particular the PTP package can extrude the formulation 20 from the outside by pushing the formulation 20 together with the PTP from the outside with the finger or the like, so that the formulation 20 inside can be taken out.
  • FIG. 2 is a longitudinal sectional view schematically showing the structure of a laminate that is a material of the PTP or blister pack 40.
  • the laminated structure shown in FIG. 2 remains in the form after the laminated body of materials is formed as PTP or blister pack 40 (enclosed portion indicated by a two-dot chain line in FIG. 1: reference symbol II).
  • the structure of the laminated body (PTP or the laminated body for blister packs) used as the material of PTP or the blister pack 40 is demonstrated taking the laminated structure of FIG. 2 as an example.
  • the PTP or blister pack 40 includes a base material layer 70 in the outermost layer and an absorption film (absorption layer) 50 on the inner side facing the contents.
  • the absorption film 50 is laminated on the base material layer 70 via the adhesive layer 60.
  • the base material layer 70 PVC, PVC coated with polyvinylidene chloride (PVDC), PP, or the like can be used.
  • the base material layer 70 may be a single layer, but may be composed of two or more layers including other layers such as an AL foil as long as the PTP moldability, gas barrier property, and water vapor barrier property are not impaired.
  • the thickness is preferably 150 to 300 ⁇ m from the viewpoint of PTP moldability.
  • the absorption film 50 and the base material layer 70 are laminated via the adhesive layer 60 by dry lamination or sand lamination.
  • the adhesive layer 60 an adhesive for dry lamination, low density polyethylene (LDPE), linear low density polyethylene (LLDPE), or the like can be used.
  • LDPE low density polyethylene
  • LLDPE linear low density polyethylene
  • an anchor coat layer may be provided on either or both of the absorption film 50 and the base material layer 70.
  • the absorption film 50 is a film having a three-layer structure. That is, the absorption film 50 includes an intermediate layer 51 and an outer skin layer 52 and an inner skin layer 53 sandwiching the intermediate layer 51.
  • middle layer 51 makes the core as a functional layer which mainly bears absorption of a water
  • the outer skin layer 52 and the inner skin layer 53 are mainly formed as a skin layer of the intermediate layer 51 by being laminated inside and outside (up and down as viewed in the lamination direction) with the intermediate layer 51 interposed therebetween.
  • the outer skin layer 52 is laminated with the base material layer 70 through the adhesive layer 60, and the inner skin layer 53 is disposed on the inner side facing the contents in the PTP or blister pack 40.
  • the inner and outer skin layers 52 and 53 are not given an absorption function.
  • a polyethylene resin such as LDPE or LLDPE can be used.
  • the intermediate layer 51 is composed of a mixture of a polyethylene resin and an absorbent, and the proportion of the absorbent in the entire mixture is preferably 10 to 30% by mass, and the proportion of polyethylene as the resin is preferably 70 to 90% by mass. . If it is said mass ratio, sufficient absorption characteristic can be suitably exhibited according to the combination of the resin material used for an inner skin layer, and those mixing ratios.
  • the absorbent silica gel, zeolite, calcium oxide, magnesium sulfate, and the like can be appropriately selected depending on the object to be absorbed, such as water, water vapor, gas, and odor. In the present embodiment, zeolite having excellent odor absorption capability is preferable.
  • zeolite natural zeolite, artificial zeolite, synthetic zeolite and the like can be used. Since zeolite has a high absorption rate, it can quickly absorb moisture and odors.
  • Molecular sieve which is an example of zeolite, is a porous granular material used to separate materials according to the difference in molecular size, and has a structure with uniform pores. Absorbs molecules and acts as a kind of sieve.
  • the pore (absorption port) diameter is preferably 0.3 nm to 1 nm.
  • the molecular sieves having pore diameters of 0.3 nm, 0.4 nm, 0.5 nm, and 1 nm are respectively converted to molecular sieve 3A, molecular sieve 4A, and molecular sieve. 5A, referred to as molecular sieve 13X.
  • the average particle size of the molecular sieve is, for example, about 10 ⁇ m. In the present embodiment, these zeolites can be appropriately used according to the properties of the contents packaged in the PTP or blister pack 40.
  • hydrophobic zeolite is a generic term for a so-called high silica zeolite in which aluminum atoms in the crystal skeleton of the zeolite are reduced by dealumination to increase the silica-alumina ratio.
  • Hydrophobic zeolite is a zeolite that loses its affinity for polar substances such as water and absorbs nonpolar substances such as odor more strongly.
  • hydrophobic molecular sieves have a pore diameter of 0.6 to 0.9 nm.
  • Abscents 1000, Abscents 2000, Abscents 3000 aboveve, manufactured by Union Showa Co., Ltd.
  • the pore diameter can be confirmed by structural analysis by X-ray diffraction.
  • the average particle size of the hydrophobic zeolite is, for example, 3 to 5 ⁇ m.
  • the inner skin layer is composed of a mixed resin obtained by mixing low density polyethylene (LDPE) and high density polyethylene (HDPE) having a melting point higher than the preheating temperature, and low density polyethylene (LDPE) occupying the mixed resin. Is 25 to 50% by mass, and the high-density polyethylene (HDPE) is the remaining 75 to 50% by mass.
  • LDPE low density polyethylene
  • HDPE high-density polyethylene
  • Example of layer structure The following is an example of the layer structure of the PTP or blister pack laminate.
  • the material and thickness (layer thickness) of each layer in this layer configuration example are, for example, as follows.
  • Base material layer Material: PVC coated with PVDC (Product name: Sumilite VSL4515 Sumitomo Bakelite Manufactured), layer thickness: 230 ⁇ m
  • Anchor coat layer ⁇ AC agent for extrusion lamination main agent: Tomoflex TM-265, curing agent: Tomoflex CATRT-37 manufactured by Toyo Morton
  • Outer skin layer Material: LLDPE (1), Layer thickness: 10 ⁇ m Intermediate layer: Material: Absorbent and LLDPE (2), Layer thickness: 60 ⁇ m
  • Inner skin layer Material: Mixed resin of LLDPE (1) and high
  • LLDPE linear low density polyethylene
  • the absorbent film 50 is formed by coextrusion molding by air-cooling inflation using the prepared inner skin layer mixed pellets as the inner skin layer 53 material and the intermediate layer mixed pellets as the intermediate layer 51 material. is there.
  • the film forming conditions are as follows. Processing machine name: Three-layer inflation molding machine Manufacturer: Plako Co., Ltd. Resin temperature: 180 ° C for both intermediate and inner skin layers Take-up speed: 13m / min
  • the formed absorption film 50 is laminated with a base material layer 70 in which an anchor coat layer is formed by gravure printing on the surface to be bonded through an adhesive layer 60 by a sand laminating method, and this is laminated to a material of PTP or blister pack 40 (PTP or blister pack laminate).
  • the anchor coat layer is omitted. (The same applies to the following.)
  • PTP or blister pack molding conditions A PTP or blister pack 40 was formed using the above laminate.
  • the molding conditions are as follows. Machine name: FBP-600UC Manufacturer: CKD Corporation Processing method: Plug assist molding Preheating set temperature: Heating plate 130 ° C Plug temperature: 125 ° C Processing speed: 250 shots / min
  • Seal conditions are as follows. Sealing machine name: Thermal tilt tester Manufacturer: Toyo Seiki Seisakusho Co., Ltd. Sealing pressure: 0.15 MPa Sealing temperature: 210 ° C Sealing time: 0.2 seconds Sealing width: 10 mm
  • the lid member has a structure shown in the following materials.
  • Manufacturer Sumi Light Aluminum Foil Co., Ltd.
  • Product name Printing aluminum foil (for CPP)
  • Material Heat-resistant overcoat layer / AL (aluminum) 17 ⁇ m / Adhesive resin layer
  • FIG. 3 is a list showing the brand, model number, manufacturer name, melting point, etc. of the resin used in the laminate.
  • the brand (product name) in FIG. 3 includes a registered trademark.
  • “LLDPE (1)” and “LLDPE (2)” shown in FIG. 3 correspond to “LLDPE (1)” and “LLDPE (2)” in the layer configuration example described above, respectively. .
  • PP (1) and “PP (2)” shown in FIG. 3 are the abbreviations “PP” for “polypropylene” followed by “(1)”, “(2)”, etc. These are given in parentheses, and these mean identifiers (serial numbers) of resins of different brands used.
  • the difference between “PP (1)” and “PP (2)” is in particular their melting point. That is, “PP (1)” has a melting point of 151 ° C., which is higher than the preheating temperature (130 ° C.) applied in the molding process of PTP or blister pack 40. In contrast, “PP (2)” has a melting point of 124 ° C., which is lower than the preheating temperature (130 ° C.).
  • the absorbent contained in the intermediate layer 51 is as follows. Absorbent: Zeolite Product name / model: Abscents 3000 (Union Showa Co., Ltd.)
  • the inventors manufactured a plurality of experimental samples under the conditions of the above layer configuration example, and evaluated each sample from the viewpoint of preheat resistance and absorption characteristics. And the range suitable as an Example of this invention was verified about the layer structure example from the evaluation result.
  • FIG. 4 is a list showing the verification results of the experimental samples (Nos. 1 to 14) regarding the layer configuration example.
  • each experimental sample No. The absorption film 50 is actually blow-molded at the resin mixing ratios 1 to 14 (Nos. 1, 6, 10, and 14 are independent).
  • the PTP 40 is actually formed using a laminate in which the absorption film 50 obtained from the laminate is laminated in the same manner as in the layer configuration example, and evaluated from the following three viewpoints (A), (B), and (C). went.
  • the inner skin layer 53 was visually inspected to evaluate whether or not it was fused to the preheat plate (heating plate).
  • the visual observation in the molding process is performed after the sheet-like laminate passes through the preheat plate, for example.
  • the pass / fail evaluation was “ ⁇ ” and “ ⁇ ”, and the pass “ ⁇ ” was determined to correspond to the case where no fusion to the preheat plate occurred. Moreover, it was decided that “x” of failure was applicable when fusion to the preheat plate occurred.
  • the PTP package is brought close to the tip of the nose and the odor at the time of taking out the tablet is evaluated.
  • the evaluation criteria of the odor sensory test are as follows. The intensity of odor (specific odor) is classified into the following 5 levels. 1) Odorless, 2) Almost (or very slightly) 3) Slightly 4) 4) 5) Strong
  • experimental sample no. Evaluate groups 1-6.
  • Experimental sample no. FIG. 4 shows the resin brands used for the inner skin layer 53 in 1 to 6 and the mixing ratio (% by mass) for each brand in the resin of the inner skin layer 53.
  • the inner skin layer 53 is made of LLDPE or a mixed resin of LDPE and HDPE.
  • Reference numeral 1 is a positioning as a comparative example compared with the embodiment of the present invention.
  • Reference numeral 6 denotes a structure in which the inner skin layer 53 is composed of HDPE alone, and is positioned as a comparative example compared with the example of the present invention. In this case, there is no problem with the preheat resistance.
  • FIG. 5 The absorption rate (%) when 1 to 6 (excluding No. 5 in this case) is exposed to the diacetyl environment in the desiccator for 10 hours is shown.
  • the horizontal axis represents the mixing ratio (% by mass) of LLDPE with respect to HDPE of the inner skin layer 53
  • the vertical axis represents the diacetyl absorption rate (%).
  • the absorption characteristics of diacetyl due to the difference in the mixing ratio of the resin have a high correlation between the mixing ratio of LLDPE and the diacetyl absorption rate, and the higher the mixing ratio of LLDPE, the higher the diacetyl absorption capacity.
  • Experimental sample No. 1 was found to be the highest when diacetyl absorption ability was evaluated after a certain period of time. This means that LLDPE (1) alone has good gas permeability.
  • Experimental sample No. 6 has the lowest diacetyl absorption capacity, which means that HDPE alone has the worst gas permeability.
  • FIG. 6 is a list showing the results of odor sensory tests with actual drugs.
  • the specimen is a PTP package prepared by using a laminate having each configuration of 4, 5, 6, and 10 and an active drug (olmesartan medoxomil 40 mg tablet).
  • the experimental sample No. 10 (layer structure of PP (1) alone) is another experimental sample No. Evaluation was made for reference for comparison with 4, 5, and 6.
  • the sample number of each test sample is “5 days later” and “1 week later”. There was little smell in order of 4 ⁇ 5 ⁇ 10 ⁇ 6. In addition, at the time of storage “after 2 weeks”, the experimental sample No. There was little smell in order of 5 ⁇ 4 ⁇ 10 ⁇ 6.
  • experimental sample No. The average score of 10 evaluators with respect to 4 was 1.6 for both “after 5 days” and “after 1 week”, and 1.9 for “after 2 weeks”. It was rated as “I do n’t like it”. Experimental sample No. The average score of 5 was 1.9 for both “5 days later” and “1 week later”, and 1.4 for “after 2 weeks”, and “no odor” and “mostly unsatisfactory” at any storage time point. It became evaluation between.
  • the experimental sample No. 4 or No. 5 that is, the mixing ratio of LLDPE is preferably 25% or more or 10% or more. Further, from the viewpoint of not causing fusion, the LLDPE mixing ratio is preferably 50% or less.
  • Experimental sample no. 7 to 9 are groups in which the inner skin layer 53 is composed of a mixed resin of LLDPE (1) and PP (1), and these are all positioned as comparative examples.
  • Experimental sample No. 10 is an inner skin layer 53 made of a single resin of PP (1) and is similarly positioned as a comparative example.
  • Experimental sample no. The brand of resin used for the inner skin layer 53 in 7 to 10 and the mixing ratio (% by mass) for each type in the resin of the inner skin layer 53 are as shown in FIG.
  • Experimental sample No. as a comparative example The only experimental sample No. in the group of 7-10.
  • the evaluation of 10 (A) “preheat resistance” is “ ⁇ ”.
  • experimental sample no. As a result of conducting an odor sensory test using a PTP package prepared using 10 and an active drug (olmesartan medoxomil 40 mg tablet), the average score of 10 people “after 5 days” is 2.3, “1” The average scores of “after week” and “after 2 weeks” were both 2.2, and both exceeded the value of “almost no”.
  • experimental sample No. Reference numerals 11 to 13 are groups in which the inner skin layer 53 is made of a mixed resin of LLDPE (1) and PP (2), and these are all positioned as comparative examples.
  • Experimental sample No. 14 is an inner skin layer 53 made of a resin of PP (2) alone, and is also positioned as a comparative example.
  • Experimental sample no. The type of resin used for the inner skin layer 53 in 11 to 14 and the mixing ratio (mass%) by brand in the resin of the inner skin layer 53 are as shown in FIG.
  • the resin material used for the inner skin layer 53 is a mixed resin in which LLDPE (1) and HDPE having a higher melting point than the preheating temperature are mixed.
  • the ratio of LLDPE (1) in the mixed resin is in the range of 25 to 50% by mass, and the ratio of HDPE is in the range of 75 to 50% by mass. More preferably, the ratio of LLDPE (1) in the mixed resin is in the range of 10 to 50% by mass, and the ratio of HDPE is in the range of 90 to 50% by mass.
  • the molding process of the PTP or blister pack 40 is performed by molding the laminate (raw material film) by setting the mixing ratio of the resin used for the inner skin layer 53 within the above range. Sufficient preheat resistance can be obtained. Moreover, the PTP or blister pack 40 obtained by molding from the laminate can exhibit good diacetyl absorption characteristics by packaging the preparation 20 and the like using this.
  • the PTP or blister pack 40 of one embodiment is suitable for blister packaging of formulations containing olmesartan medoxomil.
  • a method for reducing the odor generation of the olmesartan medoxomil-containing preparation can be realized, and therefore the PTP or blister pack 40 of one embodiment is used. Is preferred.
  • the PTP or blister pack 40 can take a form in which an olmesartan medoxomil-containing preparation is included as the preparation 20.
  • the olmesartan medoxomil-containing preparation as the preparation 20 packaged in the PTP or blister pack 40 becomes the blister package 10 shown in FIG. (3)
  • the olmesartan medoxomil-containing preparation can be suitably marketed as a form of the blister package 10.
  • PTP or blister pack 40 can be used to package olmesartan medoxomil-containing preparations.
  • PTP or blister pack 40 can be used for odor-reducing packaging in olmesartan medoxomil-containing preparations.
  • Olmesartan medoxomil is used for hypertension or a disease derived from hypertension (more specifically, hypertension, heart disease [angina, myocardial infarction, arrhythmia, heart failure or hypertrophy), kidney disease [diabetic nephropathy, thread Spherical nephritis or nephrosclerosis] or cerebrovascular disease [cerebral infarction or cerebral hemorrhage]) is effective for prevention or treatment, and the method described in Japanese Patent No. 2082519 (US Pat. No. 5,616,599) and the like And can be manufactured easily.
  • the olmesartan medoxomil-containing preparation in the present invention may contain other active ingredients as necessary.
  • the active ingredient include diuretics such as trichlormethiazide, hydrochlorothiazide, and benzylhydrochlorothiazide (Azelnidipine salt).
  • ACAT inhibitors such as pactimibe (Pactimibe), but is not limited thereto.
  • the amount of these active ingredients
  • the olmesartan medoxomil-containing preparation of the present invention further comprises, as necessary, appropriate pharmacologically acceptable excipients, lubricants, binders, disintegrants, emulsifiers, stabilizers, flavoring agents, diluents, etc. Can be included.
  • the olmesartan medoxomil-containing preparation in the present invention is preferably a solid preparation.
  • tablets including sublingual tablets and orally disintegrating tablets
  • capsules including soft capsules and microcapsules
  • granules fine granules
  • a powder, a pill, a chewable agent, a troche, etc. can be mentioned, Preferably it is a powder, a fine granule, a granule, a capsule, or a tablet, More preferably, it is a tablet.
  • the preparation method of the present invention includes The Theory and Practice of Industrial Pharmacy (Third Edition) (Leon Lachman et al .: LEA & FEIGER 1986, pages 3-99, 293H terd, 293-37, D (Second Edition) (Herbert A. Lieberman et al .: MARCEL DEKKER INC. 1989, pages 131-284) may be used, and there is no special limitation. .
  • the tablet of the present invention is prepared by, for example, granulating, drying and sizing the active ingredient together with excipients, binders, disintegrants, etc. by a method known per se, adding a lubricant etc., mixing, and tableting.
  • the granulation can be carried out by any of wet granulation, dry granulation, and heat granulation methods. Specifically, a high-speed agitation granulator, a fluidized granulator / dryer, an extrusion It is performed using a granulator, a roller compactor, etc.
  • operations such as drying and sizing may be performed as necessary.
  • a mixture of the active ingredient and excipient, binder, disintegrant, lubricant, etc. can also be compressed directly.
  • the tablet of the present invention may be provided with at least one film coating.
  • Coating is performed using, for example, a film coating apparatus, and examples of the film coating base include sugar coating base, water-soluble film coating base, enteric film coating base, sustained-release film coating base, and the like. Can be mentioned.
  • olmesartan medoxomil-containing preparation is packaged using PTP or blister pack 40, and blister pack 10 is obtained as an experimental sample. Then, after a certain period of time has passed for the experimental sample at room temperature or heat abuse conditions, sensory evaluation by human olfaction and quantitative evaluation of diacetyl can be performed. By such a test, it can be confirmed that the PTP or blister pack of the present invention can reduce the odor generation of the olmesartan medoxomil-containing preparation.
  • the gas in the pocket of the blister package 10 is collected with a syringe and injected into a gas chromatography to measure the concentration of the detected gas component (diacetyl). The measurement conditions for gas chromatography are shown below.
  • the present invention can be implemented with various modifications and replacements without being limited to the above-described embodiments and examples. Moreover, it is needless to say that the configurations and materials of the laminate and the packaging container mentioned in the above-described embodiments and examples are all preferable examples, and can be implemented by appropriately modifying them.

Landscapes

  • Packages (AREA)
  • Wrappers (AREA)
  • Laminated Bodies (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

La présente invention concerne un corps stratifié (40) pour un emballage en PTP ou coque dans lequel une couche d'absorption (50) est déposée en couche sur une couche de substrat (70) au moyen d'une couche adhésive (60). La couche d'absorption (50) possède une configuration dans laquelle une couche d'enveloppe externe (52), une couche intermédiaire (51), et une couche d'enveloppe interne (53) sont déposées en couche dans l'ordre énoncé, et la couche d'enveloppe externe (52) est liée à la couche de substrat (70) au moyen de la couche adhésive (60). La couche d'enveloppe externe (52) est composée d'une résine de polyéthylène, la couche intermédiaire (51) est composée d'un mélange d'une résine de polyéthylène et d'un absorbant, et la couche d'enveloppe interne (53) est composée d'une résine mélangée présentant 25 à 50 % en masse d'un polyéthylène linéaire basse densité, et 75 à 50 % en masse d'un polyéthylène haute densité présentant un point de fusion en tant que matériau supérieur à la température de préchauffage dans le procédé de moulage. De préférence, la résine mélangée de la couche d'enveloppe interne (53) présente 10 à 50 % en masse d'un polyéthylène linéaire basse densité, et 90 à 50 % en masse d'un polyéthylène haute densité présentant un point de fusion en tant que matériau supérieur à la température de préchauffage dans le procédé de moulage.
PCT/JP2013/001972 2012-03-23 2013-03-22 Corps stratifié pour emballage en ptp ou coque, et emballage en ptp ou coque WO2013140821A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020147023325A KR20140124790A (ko) 2012-03-23 2013-03-22 Ptp 또는 블리스터 팩용 적층체 및 ptp 또는 블리스터 팩
JP2014506051A JP6175425B2 (ja) 2012-03-23 2013-03-22 Ｐｔｐ又はブリスターパック用積層体及びｐｔｐ又はブリスターパック
CN201380009766.XA CN104169187A (zh) 2012-03-23 2013-03-22 压出式包装或泡罩包装用叠层体以及压出式包装或泡罩包装

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012-067137 2012-03-23
JP2012067137 2012-03-23

Publications (1)

Publication Number Publication Date
WO2013140821A1 true WO2013140821A1 (fr) 2013-09-26

Family

ID=49222293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/001972 WO2013140821A1 (fr) 2012-03-23 2013-03-22 Corps stratifié pour emballage en ptp ou coque, et emballage en ptp ou coque

Country Status (5)

Country Link
JP (1) JP6175425B2 (fr)
KR (1) KR20140124790A (fr)
CN (1) CN104169187A (fr)
TW (1) TW201347988A (fr)
WO (1) WO2013140821A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016055639A (ja) * 2014-09-09 2016-04-21 藤森工業株式会社 多層積層体及び包装体
WO2016063987A1 (fr) * 2014-10-23 2016-04-28 共同印刷株式会社 Stratifié pour emballage-coque, emballage-coque l'utilisant, et ensemble emballage-coque, et procédé pour leur fabrication
JP2017007689A (ja) * 2015-06-18 2017-01-12 共同印刷株式会社 ブリスターパック用積層体、及びそれを用いたブリスターパック
CN106458410A (zh) * 2014-06-18 2017-02-22 共同印刷株式会社 泡罩包装用吸收层、包含其的层叠体、及使用其的泡罩包装
US20180170008A1 (en) * 2015-06-18 2018-06-21 Kyodo Printing Co., Ltd. Laminate for use in blister pack, and blister packing using same
JP2019055548A (ja) * 2017-09-22 2019-04-11 大日本印刷株式会社 低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法
JP2020055536A (ja) * 2018-09-28 2020-04-09 スタープラスチック工業株式会社 包装体用フィルム及び包装体
JP2021192797A (ja) * 2015-11-30 2021-12-23 大原薬品工業株式会社 医薬品包装箱を利用した、配合錠の両面印字情報の提供方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105372363A (zh) * 2015-10-27 2016-03-02 深圳瀚星翔科技有限公司 电子烟烟油中双乙酰含量的检测方法
JP2017178352A (ja) * 2016-03-29 2017-10-05 ニプロ株式会社 Ｐｔｐ包装体
JP7002298B2 (ja) * 2017-11-10 2022-01-20 共同印刷株式会社 ブリスターパック用蓋材
KR20200139145A (ko) * 2018-03-30 2020-12-11 다이니폰 인사츠 가부시키가이샤 악취 흡착 성형품 수지 조성물, 악취 흡착 성형품 및 포장 재료
CN114174060A (zh) * 2019-06-03 2022-03-11 阿姆科挠性物品辛根有限责任公司 用于硬质明胶胶囊的调理包装的方法
EP3808680B1 (fr) 2019-10-14 2023-05-03 GSK Consumer Healthcare SARL Emballage-coque, produit pharmaceutique ou nutritionnel conditionné et procédé de fabrication d'un tel produit
JP7499711B2 (ja) * 2021-02-01 2024-06-14 Ckd株式会社 Ｐｔｐシート及びｐｔｐシートの製造方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03182348A (ja) * 1989-12-12 1991-08-08 Nippon Unicar Co Ltd 共押出積層水冷インフレーションフィルム
JPH09308683A (ja) * 1996-05-24 1997-12-02 Fujimori Kogyo Kk 医療用液体容器用プラスチックフィルム
JP2006103737A (ja) * 2004-10-04 2006-04-20 Mitsubishi Plastics Ind Ltd 分配パッケージの蓋材用共押出フィルム
WO2006115264A1 (fr) * 2005-04-26 2006-11-02 Daiichi Sankyo Company, Limited Film pour ptp ou pour plaquette thermoformee et contenant d'emballage pour ptp ou plaquette thermoformee
WO2008050714A1 (fr) * 2006-10-25 2008-05-02 Daiichi Sankyo Company, Limited Matériel de conditionnement
WO2012029899A1 (fr) * 2010-09-01 2012-03-08 アステラス製薬株式会社 Emballage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053267A1 (fr) * 2004-11-10 2006-05-18 Avery Dennison Corporation Etiquettes surmoulees et leurs utilisations
CN101049750B (zh) * 2007-04-20 2010-10-27 上海紫泉标签有限公司 防粘热收缩薄膜

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03182348A (ja) * 1989-12-12 1991-08-08 Nippon Unicar Co Ltd 共押出積層水冷インフレーションフィルム
JPH09308683A (ja) * 1996-05-24 1997-12-02 Fujimori Kogyo Kk 医療用液体容器用プラスチックフィルム
JP2006103737A (ja) * 2004-10-04 2006-04-20 Mitsubishi Plastics Ind Ltd 分配パッケージの蓋材用共押出フィルム
WO2006115264A1 (fr) * 2005-04-26 2006-11-02 Daiichi Sankyo Company, Limited Film pour ptp ou pour plaquette thermoformee et contenant d'emballage pour ptp ou plaquette thermoformee
WO2008050714A1 (fr) * 2006-10-25 2008-05-02 Daiichi Sankyo Company, Limited Matériel de conditionnement
WO2012029899A1 (fr) * 2010-09-01 2012-03-08 アステラス製薬株式会社 Emballage

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3159279A4 (fr) * 2014-06-18 2017-12-13 Kyodo Printing Co., Ltd. Couche absorbante pour plaquettes alvéolées, stratifié la comprenant et plaquette alvéolée mettant en oeuvre ledit stratifié
US10010480B2 (en) 2014-06-18 2018-07-03 Kyodo Printing Co., Ltd. Absorbing layer for blister package, laminate comprising same, and blister package using said laminate
CN106458410A (zh) * 2014-06-18 2017-02-22 共同印刷株式会社 泡罩包装用吸收层、包含其的层叠体、及使用其的泡罩包装
JP2020097243A (ja) * 2014-09-09 2020-06-25 藤森工業株式会社 多層積層体及び包装体
JP2016055639A (ja) * 2014-09-09 2016-04-21 藤森工業株式会社 多層積層体及び包装体
JPWO2016063987A1 (ja) * 2014-10-23 2017-08-03 共同印刷株式会社 ブリスターパック用積層体、それを用いたブリスターパック、及びブリスターパック包装体、並びにその積層体の製造方法
CN107074419A (zh) * 2014-10-23 2017-08-18 共同印刷株式会社 泡罩包装用层叠体、使用其的泡罩包装、和泡罩包装包装体、以及该层叠体的制造方法
WO2016063987A1 (fr) * 2014-10-23 2016-04-28 共同印刷株式会社 Stratifié pour emballage-coque, emballage-coque l'utilisant, et ensemble emballage-coque, et procédé pour leur fabrication
US20180170008A1 (en) * 2015-06-18 2018-06-21 Kyodo Printing Co., Ltd. Laminate for use in blister pack, and blister packing using same
JP2017007689A (ja) * 2015-06-18 2017-01-12 共同印刷株式会社 ブリスターパック用積層体、及びそれを用いたブリスターパック
JP2021192797A (ja) * 2015-11-30 2021-12-23 大原薬品工業株式会社 医薬品包装箱を利用した、配合錠の両面印字情報の提供方法
JP7334218B2 (ja) 2015-11-30 2023-08-28 大原薬品工業株式会社 医薬品包装箱を利用した、配合錠の両面印字情報の提供方法
JP2019055548A (ja) * 2017-09-22 2019-04-11 大日本印刷株式会社 低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法
JP6992358B2 (ja) 2017-09-22 2022-01-13 大日本印刷株式会社 低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法
JP2020055536A (ja) * 2018-09-28 2020-04-09 スタープラスチック工業株式会社 包装体用フィルム及び包装体
JP7178855B2 (ja) 2018-09-28 2022-11-28 スタープラスチック工業株式会社 包装体用フィルム及び包装体

Also Published As

Publication number Publication date
JPWO2013140821A1 (ja) 2015-08-03
TW201347988A (zh) 2013-12-01
KR20140124790A (ko) 2014-10-27
CN104169187A (zh) 2014-11-26
JP6175425B2 (ja) 2017-08-02

Similar Documents

Publication Publication Date Title
JP6175425B2 (ja) Ｐｔｐ又はブリスターパック用積層体及びｐｔｐ又はブリスターパック
CN101528179B (zh) 包装材料
CA2664380C (fr) Emballage medical
US10239680B2 (en) Blister package containing the laminated sheet and container
JP4659523B2 (ja) ブリスター用フィルム及びブリスター用包装容器
JP5849001B2 (ja) Ｐｔｐ又はブリスターパック用積層体、及びこれを用いて成形されたｐｔｐ又はブリスターパック
EP3312004B1 (fr) Stratifié pour une utilisation dans une plaquette alvéolaire et plaquette alvéolaire l'utilisant
TW201615422A (zh) 易剝離性的包裝袋
EP2098249B1 (fr) Véhicules de nicorandil dotés d'une stabilité améliorée
JP2019214419A (ja) ブリスターパック用蓋材
JP7002298B2 (ja) ブリスターパック用蓋材
JP7320938B2 (ja) 低吸着性吸湿フィルム
JP2019089561A5 (fr)
EP3975972B1 (fr) Procédé d'emballage conditionné de capsules de gélatine dure
EP2127628A1 (fr) Emballage de dose d'unité
JP7233213B2 (ja) ブリスターパック用積層体、それを用いたブリスターパック、及びブリスターパック包装体
JP2018008729A (ja) 包装材

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13765147

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014506051

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20147023325

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13765147

Country of ref document: EP

Kind code of ref document: A1